September 20, 2017

PET/CT a dependable differentiator of types, origins of space-occupying brain lesions

PET/CT with fluorine-18-fluorodeoxyglucose (18F-FDG), the most commonly used radiotracer for PET neuroimaging and cancer patient management, is effective for differentiating between tumors, metastases and lymphomas in the brain and central nervous system, according to a study conducted in India and published online Sept. 15 in Nuclear Medicine Communications. {read more here}